u/aksel_kjaer
Contributes reviews on supplier material. Based in Ghent.
member · joined 12 Mar 2025
Comments — page 4 of 5
comment on week 96 check-in — 26kg down, fatigue manageable, one thing confusing me in c/hplc · 65 points · 1 year ago
integration decision on a shoulder changes your number by half a point on its own
comment on [Vendor] Homopeptide vs QSC on the same compound, same month, one test each in c/tirzepatide · 211 points · 1 year ago
Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.
comment on [Discussion] DEXA is doing more work than we give it credit for in c/glp1muscle · 5 points · 1 year ago
Sceptical. If this were true we would see it reflected in the data and we do not.
comment on [Discussion] the ACHIEVE advice in here is 11 years out of date in c/orforglipron · -15 points · 1 year ago
the small molecule is whether this actually works long-term
comment on anyone else notice lean mass kicking in around week 24 in c/glp1muscle · -14 points · 1 year ago
DEXA twice yearly is the pattern
comment on [Results] 12 weeks, 25kg, and FFMI was the hard part in c/glp1muscle · 34 points · 1 year ago
DEXA twice yearly is the pattern
comment on handling is the most under-discussed thing in c/progresspics in c/researchpeptides · 4 points · 1 year ago
thymosin fragments, GH secretagogues, secretagogue, long tail
comment on what changed for me between week 60 and week 8 in c/orforglipron · 39 points · 1 year ago
Genuine question — what concentration were you at?
comment on week 71 check-in — 17kg down, fatigue manageable, one thing confusing me in c/tirzepatide · -11 points · 1 year ago
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
comment on [Question] New Zealand — has anyone got a straight answer on non-peptide in c/orforglipron · 23 points · 1 year ago
The constipation was genuinely awful for three weeks and then simply stopped. I know that is not useful information, but it is what happened.
comment on genuine question about ATTAIN that I am slightly embarrassed to ask in c/orforglipron · 79 points · 1 year ago
phase 13 data is interesting, phase 18 will tell the real story
comment on [Discussion] we are measuring LC-MS at the wrong time and calling it noise in c/hplc · 36 points · 1 year ago
Injection volume and flow rate? Those affect resolution.
comment on what would you tell week-1 you about gradient in c/hplc · 86 points · 1 year ago
That is net peptide content, not purity. Different number, different meaning.
comment on oral GLP-1 is the most under-discussed thing in c/darkspot in c/orforglipron · 2 points · 1 year ago
My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.
comment on the SURPASS thing finally clicked for me and I want to write it down in c/tirzepatide · 10 points · 2 years ago
the 15mg is the top of the pen, not the required dose
comment on integration — 21 things I got wrong before I got it right in c/hplc · 38 points · 2 years ago
That is net peptide content, not purity. Different number, different meaning.
comment on [Lab] 13th independent test on BCH, and the trend is the interesting part in c/tirzepatide · 0 points · 2 years ago
Cosigning. The GIP contribution is real and the side effects are not simply scaled versions.
comment on the integration thing finally clicked for me and I want to write it down in c/hplc · 650 points · 2 years ago
integration decision on a shoulder changes your number by half a point on its own
comment on handling: the version I wish someone had shown me in week 1 in c/researchpeptides · 1 points · 2 years ago
You have restated the marketing copy. What is the actual substance here.
comment on [Discussion] the small molecule advice in here is 17 years out of date in c/orforglipron · 7 points · 2 years ago
Strongly agree. The supply impact would be huge.